Client Alerts & Insights
Cannabis Securities Law Update: Shareholder Suit Based on Vague Descriptions Of Product Quality Dismissed as Mere Puffery
May 29, 2020
Authored By:
New York court dismisses securities fraud claim alleging that cannabis producer misrepresented that its product is “high-quality” despite shipment containing mold and rubber gloves.
On May 15, 2020, Justice Barry R. Ostrander, presiding in the Commercial Division of the New York Supreme Court, issued an opinion that impacts the developing body of cannabis law, as well as securities fraud law. In the Matter of Sundial Growers Inc. Securities Litigation, a putative class of U.S. investors in the Canadian company Sundial Growers, Inc. (“Sundial”) brought a securities fraud complaint against Sundial, its officers and directors, and its underwriters, based on their alleged misrepresentations in the company’s prospectus and registration statement that Sundial was a producer of “high-quality” and “premium” cannabis.
In the company’s securities filings, Sundial represented that it believed its high-quality and premium cannabis would “deliver superior consumer experiences, resulting in strong consumer loyalty and advocacy.” According to the plaintiffs, just weeks later, the media reported that one of Sundial’s customers returned a half ton of cannabis because it contained mold, rubber gloves, and other non-cannabis material. On that basis, the plaintiffs alleged that Sundial’s assertions concerning the “high-quality” of its product was false and Sundial actually produced “low-quality” cannabis.
Justice Ostrander, however, ruled that the plaintiffs had failed to allege an actionable misrepresentation and he granted Sundial’s motion to dismiss their complaint: “Expressions of puffery and corporate optimism are not actionable under the securities laws,” and Sundial’s statements that its product was “premium” and “high-quality” clearly fell into that category because they were opinions that are “not subject to verification.” The court also noted that Sundial expressly disclosed in its securities filings that its business faced substantial risks, including risks concerning failures in its quality control systems.
The court’s decision in Sundial has implications beyond securities fraud cases and it demonstrates the precautions that cannabis producers should employ whenever they promote the quality of their product. Indeed, whether cannabis producers are promoting their product to investors or customers, they will be in a stronger position to defend themselves against claims of fraud, or avoid litigation in the first place, if their representations and warranties appear to be “corporate optimism” and general opinion instead of verifiable facts. For example, a company’s claim that its product is “the best” is reasonably understood to be puffery, whereas a claim by a company that its product is “higher quality than all competitors” could conceivably be verified and therefore actionable if untrue.
Benesch has robust cannabis and securities fraud practices, and is uniquely situated to advise your business as it grows and represent its interests when disputes emerge. Benesch’s seasoned cannabis attorneys represent companies all over the country, and the firm covers every aspect of the industry’s legal needs.
Benesch’s attorneys have also helped clients prevail in some of the largest securities fraud actions in the US. For example, Benesch attorneys obtained a complete victory for a defendant in a securities fraud lawsuit alleging over $20 billion in damages. They also obtained summary judgment in a securities fraud lawsuit seeking over $2 billion in damages, and persuaded the Eleventh Circuit Court of Appeals to affirm the district court’s order.
For more information, contact a member of Benesch’s Cannabis Industry Group.
Bryna Dahlin at bdahlin@beneschlaw.com or 312.624.6340.
Latest News
Word on the Street: State AGs Set Their Sights on Antitrust, Data Centers and Healthcare
State attorneys general are poised to take a larger role in antitrust and consumer protection enforcement as they fill perceived gaps left by federal regulators. Businesses should expect greater scrutiny of mergers, private equity roll-ups, healthcare transactions and other deals that affect local markets.
USPS Highway Contract Route Carrier Legal Issues for Closing Out 2026
As we approach the end of 2026, Highway Contract Route (“HCR”) carriers and brokers operating in the USPS surface transportation …
A Brave New World: Trying Causation in PFAS Cases Under CERCLA
The D.C. Circuit recently held that the EPA reasonably classified PFOA and PFOS as hazardous substances under CERCLA, clearing the way for additional cleanup and cost-recovery claims involving PFAS contamination.
Anti-SLAPP Laws on the Rise: Key Developments Since 2025
States across the country are expanding anti-SLAPP protections, with nine states enacting or strengthening laws since 2025. Most have adopted the Uniform Public Expression Protection Act (UPEPA), giving defendants new tools to seek early dismissal of lawsuits.